The Gallo Laboratory focuses on the experimental therapeutics of brain tumors that is cast into a foundation of pharmacokinetic [PK], and pharmacodynamic [PD] methods and strategies. Read More
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression
May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice
May 17, 2013 - The study, led by James C. Iatridis, PhD, was published in the journal PLOS ONE on May 17.
James Gallo, PhD
1468 Madison Avenue
New York, NY 10029